Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 735,984 | 0.00 | 735,984 |
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 3,787,940 | 0.00 | 3,787,940 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 3,349,538 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,006,624 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-2 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 8,830,901 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-1 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,401,771 | 0.00 | 0 |
9 May 23 | SLRN Acelyrin | Common Stock | Buy | Acquire P | No | No | 18 | 1,250,000 | 22.50 mm | 9,790,729 |
9 May 23 | SLRN Acelyrin | Common Stock | Conversion | Acquire C | No | No | 0 | 8,540,729 | 0.00 | 8,540,729 |
9 May 23 | SLRN Acelyrin | Series C Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 2,038,148 | 0.00 | 0 |
9 May 23 | SLRN Acelyrin | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 2,445,786 | 0.00 | 0 |